Skip to content
Clinical Trials – home
Aalborg University Hospital
Sponsor

Aalborg University Hospital

Denmark Hobrovej 18-22, 9000 Aalborg, Denmark

About the sponsor

The institution demonstrates significant involvement in advanced cardiovascular imaging techniques, with particular emphasis on cardiac computed tomography and coronary artery assessment. Research activities focus on evaluating coronary stenosis and developing improved diagnostic protocols for patients with suspected or confirmed coronary artery disease. Studies examine the clinical utility of CT coronary angiography in various patient populations, including those presenting with acute chest pain and individuals requiring comprehensive cardiac evaluation.

  • Coronary CT Angiography Optimization
  • Cardiac Imaging Protocol Development
  • Non-invasive Coronary Assessment
  • Chest Pain Diagnostic Pathways

The research portfolio includes investigations into myocardial perfusion imaging and the integration of multiple imaging modalities to enhance diagnostic accuracy in cardiovascular conditions. Special attention is given to refining imaging techniques that can guide clinical decision-making in ischemic heart disease.

About Specializations

Aalborg University Hospital runs clinical trials in conditions such as Follicular lymphoma, Drug use disorder, Diffuse large B-cell lymphoma, Anaplastic large cell lymphoma T- and null-cell types, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

17 clinical trials

Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Placebo
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · Healthy volunteers
  • Substances:NALDEMEDINE
  • Sponsor:Aalborg University Hospital
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amiodarone Hydrochloride
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Gemcitabine
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Cariprazine
  • Sponsor:Aalborg University Hospital
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:(S)-2,2',2''-(10-(2-(4-(3-((4-(2-(2-Cyano-4,4-Difluoropyrrolidin-1-Yl)-2-Oxoethylcarbamoyl)-Quinolin-6-Yl)(Methyl)Amino)-Propyl)Piperazin-1-Yl)-2-Oxoethyl)-68Ga-[1,4,7,10]-Tetraazacyclododecane-1,4,7-Triyl)Triacetate
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Aalborg University Hospital

Brain abscess

Recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Aalborg University Hospital

Mantle cell lymphoma+2

Not yet recruiting
Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Zoledronic Acid
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Clostridium Botulinum Neurotoxin Type A (150Kd), Free Of Complexing Proteins
  • Sponsor:Aalborg University Hospital
Countries:DenmarkDenmark
  • Participants:65+ years
  • Substances:Abatacept
  • Sponsor:Aalborg University Hospital

Herpes simplex meningitis

Not yet recruiting
Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Aciclovir
  • Sponsor:Aalborg University Hospital

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.

Legal notice · Published by CTIN POLAND sp. z o.o., ul. rtm. Witolda Pileckiego 67/109, 02-781 Warsaw, Poland · KRS 0001111334 · REGON 528919042 · NIP 9512598637

© 2026 Clinical Trials EU – European Clinical Trials Information Network

GDPR compliance, ISO 9001 and ISO 27001 certified (LL-C Certification)

On this site, “treatment” means an investigational medicine being studied in a clinical trial. Its safety and efficacy for the use being studied have not yet been confirmed, some participants may receive a placebo or a comparator medicine, and taking part does not guarantee any health benefit. The decision to take part is made by the doctor at the research site. This site is for information only and does not replace medical advice.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic sites, national regulators and commercial sponsors. On this site, “treatment” and “therapy” mean a medicine being tested in a clinical trial. Its safety and effectiveness in the use being studied are not yet confirmed, some participants may receive a placebo or a comparator, and taking part does not guarantee a health benefit. The doctor at the research site decides who can take part. This site provides information, not medical advice. Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).